| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,075 |
977 |
$91K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,105 |
924 |
$61K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
787 |
723 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,195 |
735 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
112 |
110 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
948 |
761 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
451 |
396 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14 |
13 |
$539.89 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
125 |
105 |
$463.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
443 |
406 |
$224.72 |
| 87807 |
|
12 |
12 |
$153.27 |
| 81003 |
|
20 |
15 |
$33.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
14 |
$22.18 |
| 99072 |
|
128 |
110 |
$0.00 |